MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 53 filers reported holding MACROGENICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $926,628 | -12.6% | 198,847 | +0.4% | 0.00% | – |
| Q2 2023 | $1,059,851 | -25.3% | 198,103 | +0.1% | 0.00% | – |
| Q1 2023 | $1,419,180 | +2.1% | 197,933 | -4.4% | 0.00% | – |
| Q4 2022 | $1,389,843 | +90.4% | 207,130 | -1.8% | 0.00% | – |
| Q3 2022 | $730,000 | +29.7% | 210,979 | +10.5% | 0.00% | – |
| Q2 2022 | $563,000 | -67.8% | 190,885 | -3.8% | 0.00% | – |
| Q1 2022 | $1,749,000 | -44.8% | 198,482 | +0.5% | 0.00% | -100.0% |
| Q4 2021 | $3,171,000 | -23.2% | 197,574 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $4,128,000 | -12.2% | 197,106 | +12.6% | 0.00% | 0.0% |
| Q2 2021 | $4,703,000 | -48.4% | 175,088 | -38.9% | 0.00% | -50.0% |
| Q1 2021 | $9,123,000 | +76.9% | 286,451 | +27.0% | 0.00% | +100.0% |
| Q4 2020 | $5,158,000 | -4.4% | 225,633 | +5.3% | 0.00% | 0.0% |
| Q3 2020 | $5,396,000 | -8.0% | 214,216 | +2.0% | 0.00% | -50.0% |
| Q2 2020 | $5,867,000 | +384.1% | 210,106 | +0.9% | 0.00% | – |
| Q1 2020 | $1,212,000 | -47.2% | 208,299 | -1.3% | 0.00% | -100.0% |
| Q4 2019 | $2,297,000 | -4.7% | 211,003 | +11.7% | 0.00% | 0.0% |
| Q3 2019 | $2,410,000 | -29.1% | 188,867 | -5.7% | 0.00% | 0.0% |
| Q2 2019 | $3,398,000 | +12.6% | 200,289 | +19.3% | 0.00% | 0.0% |
| Q1 2019 | $3,019,000 | +47.3% | 167,909 | +4.1% | 0.00% | 0.0% |
| Q4 2018 | $2,049,000 | -40.8% | 161,345 | -0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,459,000 | +4.2% | 161,366 | +0.4% | 0.00% | 0.0% |
| Q2 2018 | $3,318,000 | -20.5% | 160,654 | -3.2% | 0.00% | 0.0% |
| Q1 2018 | $4,174,000 | +43.5% | 165,897 | +8.3% | 0.00% | 0.0% |
| Q4 2017 | $2,909,000 | -2.4% | 153,121 | -5.1% | 0.00% | 0.0% |
| Q3 2017 | $2,981,000 | +6.5% | 161,330 | +0.9% | 0.00% | 0.0% |
| Q2 2017 | $2,799,000 | +11.8% | 159,839 | +18.8% | 0.00% | 0.0% |
| Q1 2017 | $2,503,000 | -11.6% | 134,560 | -2.9% | 0.00% | 0.0% |
| Q4 2016 | $2,832,000 | -28.0% | 138,552 | +5.3% | 0.00% | 0.0% |
| Q3 2016 | $3,934,000 | +5.0% | 131,543 | -5.3% | 0.00% | 0.0% |
| Q2 2016 | $3,748,000 | +52.0% | 138,857 | +5.6% | 0.00% | 0.0% |
| Q1 2016 | $2,465,000 | -41.4% | 131,492 | -3.2% | 0.00% | 0.0% |
| Q4 2015 | $4,207,000 | +36.4% | 135,854 | -5.6% | 0.00% | 0.0% |
| Q3 2015 | $3,085,000 | -42.1% | 143,970 | +2.5% | 0.00% | 0.0% |
| Q2 2015 | $5,332,000 | +34.5% | 140,426 | +11.1% | 0.00% | 0.0% |
| Q1 2015 | $3,965,000 | +11.2% | 126,387 | +24.3% | 0.00% | 0.0% |
| Q4 2014 | $3,567,000 | +105.6% | 101,718 | +22.6% | 0.00% | – |
| Q3 2014 | $1,735,000 | -45.6% | 82,973 | -43.5% | 0.00% | – |
| Q2 2014 | $3,192,000 | +318.3% | 146,940 | +436.2% | 0.00% | – |
| Q1 2014 | $763,000 | +40.0% | 27,404 | +37.9% | 0.00% | – |
| Q4 2013 | $545,000 | – | 19,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
| INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
| DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
| BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
| TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
| Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
| Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
| First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |